The future in Healthcare Logistics

Highly automated logistics centres with short delivery times are crucial for the supply chain of pharmaceutical and other healthcare products throughout Europe. PHOENIX group is a leading integrated healthcare provider present in 27 European countries. Our international logistics network includes 40 warehouses and several Hubs throughout Europe. With our long-standing presence in the different pharmaceutical markets, we have extensive experience and market knowledge to support manufacturers.

About Nomeco

Nomeco is part of the PHOENIX group, a leading integrated healthcare provider in Europe with international headquarters in Mannheim, Germany. The PHOENIX group is represented in 27 European countries with over 37,000 employees. Nomeco is a specialist in healthcare logistics with the aim of providing citizens with punctual access to medicines and other health products.

As the leading pharmaceutical wholesaler for Danish pharmacies and hospitals, Nomeco is well-known in the Nordic region. Nomeco HealthCare Logistics is the preferred strategic service and logistics partner for the international pharmaceutical industry in the Nordic and Baltic countries.

State of the art warehouse in Køge

In November 2019, Nomeco, the Danish subsidiary of the PHOENIX group, has opened the largest logistics centre for pharmaceuticals and healthcare products in the Nordic countries. After three years of construction, the healthcare logistics warehouse and distribution centre has been completed and impresses with many superlatives: The 25,000 square metre building is the size of three football fields and has a fully automated warehouse. With a height of 30 meters, it offers space for more than 55,000 pallets. Thanks to the high degree of automation, up to 1,000 pallets can be moved per hour. Based on the order history, algorithms determine the best possible storage location for each product to ensure the highest efficiency in the inbound and outbound processes.

Scandinavia's largest pharmaceutical logistics centre

"The central aspects of the construction of our logistics centre were efficiency, quality and security. In an industry where delivery reliability goes hand in hand with patient safety, this is crucial. With the new logistics centre in Køge, we continue to optimise our supply chain and make medicines available to the patients even faster," said Henrik Kaastrup, Managing Director of Nomeco.

Geographically, Denmark and Køge, south of Copenhagen, is the ideal location for short distances to the whole of Northern Europe. In Scandinavia, the PHOENIX group is present with the pharmacy chain Apotek1 in Norway and in Finland, Sweden, and the Baltics with the pharmaceutical wholesaler Tamro. PHOENIX also operates BENU pharmacies in the Baltic States.

Go to article: Home | Covid-19 and the anti-vax movementGo to article: In this issueGo to article: ContentsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Mettler Toledo Company InsightGo to article: Mettler ToledoGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: WipotecGo to article: PuroliteGo to article: VEGA AustraliaGo to article: Gerteis Company Insight Go to article: GerteisGo to article: CommentGo to article: US election: Trump and Biden's priorities in the Covid-19 responseGo to article: Covid-19 disruption to trials declines, but recruitment is slowGo to article: Covid-19 vaccine developments across the globeGo to article: Eli Lilly and Regeneron’s EUA bids trigger concerns over available Covid-19 dataGo to article: AstraZeneca’s quick Covid-19 vaccine trial restart splits opinionGo to article: Q&A: Atomwise’s journey from discoverer to developerGo to article: Pfeiffer VacuumGo to article: Koehler eClinicalGo to article: Phoenix Company Insight Go to article: PhoenixGo to article: In DepthGo to article: How to combat vaccine hesitancy in the age of Covid-19Go to article: How Covid-19 has put clinical research’s diversity problem in the spotlight Go to article: No need for animal testing: improving vaccine research with GenoskinGo to article: Gout: drug development for an age-old diseaseGo to article: Treating chronic primary pain in the UKGo to article: Breast cancer breakthrough: could a new therapy silence stubborn TNBC?Go to article: Is quantum computing pharma's next big disruptor?Go to article: MimotopesGo to article: OptelGo to article: Solvias Company Insight Go to article: SolviasGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: IWA Consulting Company Insight Go to article: IWA consultingGo to article: Nipro pharmapackagingGo to article: SwiftpakGo to article: EventsGo to article: Next issue